Increased IL‐6 and Potential IL‐6 trans‐signalling in the airways after an allergen challenge is a research paper published in Clinical & Experimental Allergy (2021). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL56396
National Institutes of Health
Grant: HL64066
National Institutes of Health
Grant: M01RR03186
National Institutes of Health
Grant: P01 HL088594
National Institutes of Health
Grant: UL1 RR025011
NIAID NIH HHS
Grant: U19 AI104317
NCRR NIH HHS
Grant: M01 RR003186
NHLBI NIH HHS
Grant: R01 HL064066
NHLBI NIH HHS
Grant: R01 HL123284
NCATS NIH HHS
Grant: UL1 TR002373
NHLBI NIH HHS
Grant: P50 HL056396
National Institutes of Health
Grant: 5P01HL088594-02
Regulation of TGF-B1 Production and Signaling by Pin-1
National Institutes of Health
Grant: 5UL1RR025011-04
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
FWCI
2.03
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Additional file 1 of Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling
Additional file 2 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 2 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 5 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 5 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 4 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 1 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 1 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 4 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 3 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
Additional file 3 of Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology